Benchling provides a unified R&D platform that accelerates, measures, and forecasts R&D – from discovery through bioprocessing – all in one place.
Nulla adipisicing do ut aliquip elit tempor fugiat. Mollit est exercitation excepteur ea consequat ullamco Lorem ex id. Ipsum nostrud Lorem dolor nisi do est in ex amet eu nostrud. Amet commodo consectetur enim nostrud dolore sint excepteur irure aliqua consectetur. Veniam occaecat et enim eiusmod qui fugiat eiusmod eiusmod laborum exercitation veniam ipsum velit. Ut veniam cupidatat ea tempor ad ad exercitation amet qui. Esse commodo sint deserunt ut elit minim sint. Amet laborum ut adipisicing minim sunt cillum anim in est ipsum aliquip anim in tempor pariatur.
Advancing Human Health
Progressing Science Knowledge
Lux investment: 2020
Saji Wickramasekara
Ashu Singhal
Benchling
Similar companies
Hugging Face is on a mission to advance and democratize Natural Language Processing.
Infrastructure Computer Science
Progressing Science Knowledge
Increasing Productivity Efficiency
Lux investment: 2019
Clément Delangue
Julien Chaumond
Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.
Biology Biochemistry
Advancing Human Health
Progressing Science Knowledge
Lux investment: 2019
Eric Betzig
Robert Tjian
Luke Lavis
Xavier Darzacq
Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gut-brain axis.
Biology Biochemistry
Advancing Human Health
Lux founded: 2015
Richard Axel
Tom Maniatis
Charles Zuker
Adam Goulburn
Nancy Thornberry
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Biology Biochemistry
Advancing Human Health
Progressing Science Knowledge
Lux investment: 2016
IPO: 2021
Chris Gibson, PhD
Blake Borgeson, PhD
Dean Li, PhD
Auris Healthis an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.
Engineering Electronics
Advancing Human Health
Increasing Productivity Efficiency
Lux investment: 2012
Acquired by JNJ: 2019
Fred Moll